HIV-Associated Diffuse Large B-Cell Lymphoma: Outcome With Uniform DA-EPOCH-R Protocol

被引：0
|
作者：
Gogia, Ajay [1 ]
Kirar, Sudhir [1 ]
Sharma, Atul [1 ]
Gupta, Ritu [1 ]
Mallick, Soumya [1 ]
机构：
[1] All India Inst Med Sci, New Delhi, India
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
ABCL; HIV; diffuse large B-cell lymphoma; outcome; DA-EPOCH-R; AIDS;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ABCL-167
引用
收藏
页码：S421 / S421
页数：1
相关论文
共 50 条
  • [21] Derangements of immunological proteins in HIV-associated diffuse large B-cell lymphoma: the frequency and prognostic impact
    Vaughan, Jenifer
    Patel, Moosa
    Suchard, Melinda
    Gededzha, Maemu
    Ranchod, Heena
    Howard, Wayne
    Snyman, Tracy
    Wiggill, Tracey
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [22] Efficacy and Feasibility of DA-EPOCH-R in Aggressive B-Cell Lymphoma: A Real Life Single-Center Analysis
    Marino, Fabrizio
    Balzarotti, Monica
    Ricci, Francesca
    Mazza, Rita
    Santoro, Armando
    Carlo-Stella, Carmelo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S250 - S250
  • [23] DA-EPOCH-R VS R-CHOP in Patients with Primary Mediastinal Large B-Cell Lymphoma: Results of Prospective Randomized Ukrainian Multicenter Study
    Stepanishyna, Yana
    Skrypets, Tetiana
    Novosad, Olga
    Pastushenko, Ian
    Kryachok, Irina
    BLOOD, 2020, 136
  • [24] DA-EPOCH-R followed by consolidation with autologous stem cell transplantation in the first-line treatment of poor-risk, diffuse large B-cell lymphoma - a single center experience
    Prka, Zeljko
    Lucijanic, Marko
    Vasilj, Tamara
    Mitrovic, Zdravko
    Jaksic, Ozren
    Pejsa, Vlatko
    BONE MARROW TRANSPLANTATION, 2018, 53 : 606 - 606
  • [25] PILOT FEASIBILITY STUDY: DA-EPOCH-R IN THE TREATMENT OF CHILDHOOD MATURE B-CELL MALIGNANCIES
    Gulati, Nitya
    Simko, Stephen
    McClain, Kenneth
    Bollard, Catherine
    Allen, Carl
    Kamdar, Kala
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [26] DOSE-ADJUSTED EPOCH PLUS RITUXIMAB (DA-EPOCH-R) REDUCES THE RISK OF CNS RELAPSE IN PATIENTS WITH HIGH-RISK DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL): A SINGLE CENTRE EXPERIENCE
    Garcia-Suarez, J.
    De Miguel, D.
    Martin, Y.
    Gil-Fernandez, J. J.
    Pascual, T.
    Magro, H.
    Lopez-Rubio, M.
    Burgaleta, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 438 - 438
  • [27] Dose-Adjusted EPOCH and Rituximab (DA-EPOCH-R) Treatment in Dual Expressor Diffuse Large B-Cell and Double/Triple Hit Lymphomas: TP53 Mutations Influence on Clinical Outcome
    Dodero, Anna
    Guidetti, Anna
    Marino, Fabrizio
    Carniti, Cristiana
    Banfi, Stefania
    Tucci, Alessandra
    Balzarotti, Monica
    Cabras, Antonello Domenico
    Monti, Valentina
    Devizzi, Liliana Franca
    Farina, Lucia
    Di Chio, Maria Chiara
    Rossi, Giuseppe
    Carlo-Stella, Carmelo
    Corradini, Paolo
    BLOOD, 2019, 134
  • [28] EBV-driven HIV-associated diffuse large B-cell lymphoma causing profound lactic acidosis
    Prokesch, Bonnie C.
    Shiloh, Michael U.
    BLOOD, 2014, 124 (06) : 842 - 842
  • [29] Glofitamab in patients with HIV-associated B-cell lymphoma
    Tinajero, Jose
    Markary, Tanya
    Ngo, Dat
    Kambhampati Thiruvengadam, Swetha
    Ayyappan, Sabarish
    Mei, Matthew
    LEUKEMIA & LYMPHOMA, 2024,
  • [30] Survival of HIV associated diffuse large B-cell lymphoma and Burkitt lymphoma in China
    Xiong, Yu
    Liu, Weicheng
    Chen, Xiaoping
    Mo, Pingzheng
    Xiong, Yong
    Deng, Liping
    Zhang, Yongxi
    SCIENTIFIC REPORTS, 2024, 14 (01):
12345